More than 64 million people worldwide use Abbott’s medicines every day, the company says, benefiting from a portfolio designed to improve and maintain health in emerging markets.
Abbott’s product range, available only in emerging markets, focuses on women’s health, cardiometabolic conditions, gastroenterology, oncology, immunology and other areas. The company says its approach is tailored to local needs to deliver accessible, reliable treatments.
Leveraging its footprint in emerging countries and scientific heritage, Abbott aims to offer medicines that are superior to existing alternatives and supported by strong scientific evidence. Whether addressing common ailments or more serious illnesses, the company emphasizes fast, effective care to help people return to their daily lives.
Research shows that improving medication adherence enhances health outcomes and health system efficiency, underscoring the importance of accessible, evidence-based treatment options.
Leave a Reply